,

S P E A K E R S (AS OF MAY 15)

Special Session on fragile X treatment perspectives will also include Elizabeth Berry-Kravis (Rush U, Chicago), Aurore Curie (CHU and CNRS, Lyon), Will Spooren (Roche Pharmaceutical, Basel), Florian von Raison (Novartis Pharma, Basel).

17th INTERNATIONAL

WORKSHOP

Organised by Jean-Louis Mandel and Jamel Chelly

CGG CGG CGG CGG CGG CGG CGG CGG CGG CGG CGG CGG CGG CGG

FMR1 DYRK1A ARID1B STXBP1 SYNGAP1 SATB2 ANKRD11 MECP2 TCF4 CTNNB1 CASK SHANK3 TBR1 SMARCA2 ATRX MED13L SPTAN1 KDM5C SLC16A2 CUL4B IQSEC2 GRIN2B SLC2A1 SLC9A6 SMC1A EP300 FOXP1GRIN2A IL1RAPL1 SLC6A8 SETBP1 SCN8A PTCHD1 KAT6B NAA10 PQBP1 FOXG1 PDHA1 ARHGEF9 GABRB3 GATAD2B DDHD2 GRIN1 DLG3 CDKL5 GRIA3 PHF8 STAG1 AUTS2 POGZ MBD5 HCFC1 RAI1 LRP2 KAT6A ADNP ...

Fragile X and other Early-Onset Cognitive Disorders

Thomas BourgeronInstitut Pasteur, Paris, France

Randi HagermanMIND Institute, UC Davis, Sacramento, USA

Yann HeraultMouse Clinic Institute and IGBMC, Strasbourg, France Sebastien Jacquemont Department of Pediatrics CHU Sainte-Justine Research Centre, U of Montreal, Canada

Registration:http://fraxidstrasbg.sciencesconf.org/

Frank KooyDepartment of Medical Genetics, University of Antwerp, Belgium

Michael Ronemus Cold Spring Harbor Laboratory, NY, USA

Carlo Sala CNR Institute of Neuroscience Milano, Italy

Hilde Van Esch Laboratory for the genetics of Cognition, Center for Human Genetics, KU Leuven, Belgium

igbmc- UMR7104-U964 - www.igbmc.fr

September 27th to 30th, 2015 IGBMC Auditorium - Illkirch, Strasbourg, France